WIRB-Copernicus Group (WCG) Acquires Velos eResearch

WCG Acquires VeraSci

July 26, 2021

Healthcare Services

WCG acquired VeraSci, a Durham-based provider of eClinical software and specialty scientific expertise for CNS-focused clinical trials, to deepen its CNS scientific capabilities and expand remote data capture and decentralized trial solutions. VeraSci will operate as WCG VeraSci and remain headquartered in North Carolina while retaining its leadership team.

WCG (WIRB‑Copernicus Group) Acquires Statistics Collaborative, Inc.

January 23, 2020

Healthcare Services

WCG (WIRB‑Copernicus Group) acquired Statistics Collaborative, Inc., a Washington, D.C.‑based biostatistical consultancy that provides specialized statistical support for clinical trials, regulatory submissions and related research. The acquisition brings Statistics Collaborative’s nearly 30 years of biostatistics expertise into WCG’s Scientific and Regulatory Review Division to expand WCG’s capabilities for clinical trial sponsors and biopharmaceutical clients.

WCG Acquires Trifecta Clinical

December 3, 2020

Healthcare Services

WCG has acquired Trifecta Clinical, a provider of technology-enabled clinical trial site communications and training solutions including the InvestigatorSpace platform. The deal brings Trifecta's investigator training, safety letter distribution and document-exchange capabilities into WCG's suite of clinical research services while Trifecta retains its leadership and offices in Los Angeles and other locations.

Merck & Co., Inc. Acquires VelosBio Inc.

November 5, 2020

Biotechnology

Merck & Co., Inc. will acquire all outstanding shares of clinical-stage biopharmaceutical company VelosBio for $2.75 billion in cash. The acquisition adds VelosBio's lead investigational antibody-drug conjugate VLS-101 and ROR1-directed pipeline assets to Merck's oncology portfolio and is expected to close by the end of 2020, subject to customary conditions.

GHO Capital Acquires Velocity Clinical Research

July 15, 2021

Healthcare Services

Global Healthcare Opportunities (GHO) has acquired Durham-based Velocity Clinical Research from NaviMed Capital and other investors. GHO intends to support Velocity’s roll-up strategy of clinical trial sites, expand its integrated site model (including investment in technology and decentralized trial capabilities) and pursue further geographic expansion, including into Europe.

WCG Acquires The Avoca Group

May 11, 2021

Healthcare Services

WCG, a provider of clinical trial solutions, has acquired The Avoca Group, a life sciences consulting firm focused on clinical trial quality management, benchmarking and analytics. The acquisition strengthens WCG's capabilities in quality management, benchmarking and compliance to accelerate clinical research and improve trial efficiency.